Gabelli Funds’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,311,069
Closed -$7.67M 1220
2019
Q1
$7.67M Buy
+1,311,069
New +$4.47M 0.05% 415

Gabelli Funds's IMDZ Position: Q2 2019 in Review

Gabelli Funds sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,311,069 shares — an estimated $7.67M sold.

Gabelli Funds first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $7.67M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • Gabelli Funds reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
  • Gabelli Funds sold 1,311,069 Immune Design Corp. shares in Q2 2019, an estimated $7.67M.
  • Gabelli Funds first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
  • Gabelli Funds's Immune Design Corp. position peaked at $7.67M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Gabelli Funds's 13F filing for Q2 2019, filed 2 Aug 2019.